Deciphera Pharmaceuticals LLC (DCPH) Insider Trading
- $51,456,028.00
- $64,679,314.20
- Jan. 16, 2024
- Thomas Patrick Kelly
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 12, 2019 | Insider | 15,034 | $60.00 | Sell | $902,040.00 | |
| Dec. 3, 2019 | Insider | 15,034 | $51.38 | Sell | $772,446.92 | |
| Nov. 11, 2019 | Insider | 152,927 | $48.91 | Sell | $7,479,659.57 | |
| Nov. 1, 2019 | Director | 25,000 | $46.16 | Sell | $1,154,000.00 | |
| Oct. 28, 2019 | CFO | 3,750 | $44.34 | Sell | $166,275.00 | |
| Oct. 28, 2019 | Insider | 29,820 | $44.34 | Sell | $1,322,218.80 | |
| Sept. 19, 2019 | Insider | 3,000 | $35.56 | Sell | $106,680.00 | |
| Sept. 11, 2019 | Director | 22,500 | $34.97 | Sell | $786,825.00 | |
| Sept. 11, 2019 | CFO | 11,250 | $34.97 | Sell | $393,412.50 | |
| Sept. 3, 2019 | Director | 7,500 | $36.26 | Sell | $271,950.00 | |
| Aug. 16, 2019 | Major Shareholder | 350,000 | $36.42 | Sell | $12,747,000.00 | |
| Aug. 13, 2019 | CFO | 11,250 | $41.27 | Sell | $464,287.50 | |
| Aug. 13, 2019 | Insider | 148,107 | $40.92 | Sell | $6,060,538.44 | |
| Aug. 13, 2019 | Director | 22,500 | $40.77 | Sell | $917,325.00 | |
| June 19, 2019 | CFO | 177 | $25.00 | Sell | $4,425.00 | |
| June 3, 2019 | CFO | 2,100 | $25.20 | Sell | $52,920.00 | |
| May 22, 2019 | CFO | 1,473 | $25.06 | Sell | $36,913.38 | |
| May 1, 2019 | CFO | 13,500 | $22.93 | Sell | $309,555.00 | |
| Feb. 19, 2019 | Insider | 9,431 | $28.85 | Sell | $272,084.35 | |
| Feb. 19, 2019 | CFO | 1,500 | $30.00 | Sell | $45,000.00 | |
| Feb. 15, 2019 | Director | 18,883 | $28.04 | Sell | $529,479.32 | |
| Feb. 13, 2019 | Director | 3,522 | $28.01 | Sell | $98,651.22 | |
| Feb. 13, 2019 | Insider | 2,866 | $28.00 | Sell | $80,248.00 | |
| Feb. 5, 2019 | Insider | 1,700 | $28.01 | Sell | $47,617.00 | |
| Feb. 5, 2019 | Director | 2,595 | $28.02 | Sell | $72,711.90 | |
| Jan. 16, 2019 | Insider | 152,629 | $26.00 | Sell | $3,968,354.00 | |
| Jan. 11, 2019 | Insider | 300 | $26.00 | Sell | $7,800.00 | |
| Jan. 7, 2019 | CFO | 5,000 | $25.18 | Sell | $125,900.00 | |
| Oct. 2, 2017 | Major Shareholder | 375,000 | $17.00 | Buy | $6,375,000.00 |
Insiders are both buying and selling Deciphera Pharmaceuticals LLC stock.
The insider traders at Deciphera Pharmaceuticals LLC are: Thomas Patrick Kelly, Michael Douglas Taylor, Matthew L Sherman, James Arthur Bristol, Daniel Lee Flynn, Christopher John Morl, Jama Pitman, Daniel C Martin, Patricia L Allen, New Leaf Venture Management Ii, Brightstar Associates Llc, Dennis Leo Walsh, Franklin Stuart Friedman, Steven L Hoerter, and Steven L. Hoerter
The most active insider trader at Deciphera Pharmaceuticals LLC is Thomas Patrick Kelly with 16 trades.
New Leaf Venture Management Ii has sold the most Deciphera Pharmaceuticals LLC stock with a total value of $25,494,000.00.
Brightstar Associates Llc has bought the most Deciphera Pharmaceuticals LLC stock with a total value of $74,789,756.00.
The most recent insider trade for Deciphera Pharmaceuticals LLC was on Jan. 16, 2024.
The single biggest insider buy for Deciphera Pharmaceuticals LLC was from Brightstar Associates Llc with a total value of $29,999,988.00 on Jan. 24, 2023.
The single biggest insider sell for Deciphera Pharmaceuticals LLC was from New Leaf Venture Management Ii with a total value of $12,747,000.00 on Aug. 16, 2019.